Re: Fwd: FDA MedWatch - Market withdrawal of Vioxx (rofecoxib) due to incr eased risk of cardiovascular events

[Guest guest]

Yep, and it makes me wonder if ibuprophen isn't next. Scary. I've taken the ibuprophen on and off for a couple of yrs now. It is also an NSAID, and look at how long it's been on the market now.

Fwd: FDA MedWatch - Market withdrawal of Vioxx (rofecoxib) due to incr eased risk of cardiovascular events

[Guest guest]

Yes, but still an NSAID, so may be same difference. Ibuprophen has been a wonderful thing for swelling around the area of my thyroid, but it could very well have been one of the causes for my foic anemia, for all I know. There was the hypo, then the ibuprophen, plus I was taking Pepsid almost every single day, sometimes with the ibuprophen every single day.

Re: Fwd: FDA MedWatch - Market withdrawal of Vioxx (rofecoxib) due to incr eased risk of cardiovascular events

Vioxx is cox-2-inhibitor. I think that makes it a different class of drug.

[Guest guest]

Guess what, I just discovered something weird. Vioxx is a 2 inhibitor, but ibuprophen is a 1 AND 2 inhibitor. How weird is THAT!? I kept trying to post a link yesterday, but both times I got the letter started with a link, my computer froze, only on those letters. One of the links was to something with Ohio in the title. There were other links on this sbjct.